1525/1/12/22 Flynn Pharma Limited and Flynn Pharma (Holdings) Limited v Competition and Markets Authority

The Tribunal made a Reasoned Order on 5 August 2022 granting an extension of time for Flynn to file a notice of appeal in respect of the CMA's decision dated 21 July 2022 regarding the supply of phenytoin sodium capsules in the UK. 

Summary of appeal published on 26 October 2022.

A case management conference in Cases 1524 and 1525 took place on 15 November 2022 where the Tribunal gave directions for the future conduct of the case, including granting the Pfizer Appellants (Case No. 1524/1/12/22) permission to intervene, and gave a ruling on the timing of the hearing of the appeal ([2022] CAT 56).

A second case management conference in Cases 1524 and 1525 took place on 17 May 2023.

A third case management conference in Cases 1524 and 1525 has been listed to take place on 20 September 2023.

The hearing of the appeals in Cases 1524 and 1525 took place on 6 November 2023 to 1 December 2023, and oral closings took place on 11 to 13 December 2023. Judgment is pending.